600566.SHG Hubei Jumpcan Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
29.03 CNY
Close of Nov 5, 2026
21.13 29.65
Market cap
CNY 26.8B
P/E
14.7x
P/B
1.88x
ROE
10.0%
Dividend yield
7.20%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600566.SHG undervalued?

Graham number
Price29.03
Graham value26.18
Premium10.9%

600566.SHG trades 10.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hubei Jumpcan Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Hubei Jumpcan Pharmaceutical Co Ltd yet.

Hubei Jumpcan Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hubei Jumpcan Pharmaceutical Co Ltd

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.

Full company profile